From predicting adverse events to enhancing diagnostic accuracy, AI will continue to have a major impact on healthcare. How can this industry balance the benefits and risks of AI? Watch this video with Eric Sandor, Genpact's business lead Pharmacovigilance, and other industry experts, as they discuss how life sciences companies will need to become instinctive enterprises – connecting, predicting, and adapting – to improve patient outcomes.
Subscribe now: [ Ссылка ]
Stay connected with us!
LinkedIn: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
#Genpact #artificialintelligence #healthcareindustry
